University of Cambridge Chair of Molecular Endocrinology
MRC Investigator and Programme Leader
Fellow and Director of Studies, King's College Cambridge
VP Human Genetics (Adrestia Therapeutics Ltd)
Biography | Employment | Publications
2022 - Ongoing
Vice President of Human Genetics, Adrestia Therapeutics Ltd
Providing human genetics leadership at Adrestia Therapeutics, a Cambridge-based biotech company using cellular 'synthetic rescue' screens to identify drug targets for selected rare disorders.
2021 - Ongoing
Professorship of Molecular Endocrinology, University of Cambridge
Elected to the established chair of Molecular Endocrinology at the Department of Clinical Biochemistry. Running an academic research group and providing human genetics leadership within the Institute of Metabolic Science's Metabolic Research Laboratory (MRL) and MRC Epidemiology Unit.
2019 - Ongoing
Affiliate Group Leader, Gurdon Institute, University of Cambridge
Joined the University of Cambridge Gurdon Institute as an affiliate group leader to strengthen basic science collaborations on DNA damage response mechanisms.
2018 - Ongoing
Fellow,
King's College Cambridge
Elected fellow and director of studies for pre-clinical medicine undergraduates. Within this role I have been a trustee of the college and sat on it's council and finance committee. I also lead undergraduate admissions for medicine and teach reproductive endocrinology at the college.
2017 - Ongoing
MRC Programme Leader, University of Cambridge
Within the MRC Epidemiology Unit I co-lead one of the seven core programmes with Professor Ken Ong. This programme is focussed on identifying and characterising early life mechanisms underlying susceptibility to metabolic disease in later life.
2013 - 2017
Senior Investigator Scientist, University of Cambridge
Moved from Oxford to join the MRC Epidemiology Unit at the University of Cambridge. Responsible for leading large-scale human genetic analyses.
2010 - 2013
Sir Henry Wellcome Fellow
Awarded a Wellcome Trust 'Sir Henry Wellcome' Fellowship to study the genetics of type 2 diabetes. During this fellowship I held academic positions at the Wellcome Trust Centre for Human Genetics at the University of Oxford; the University of Exeter Medical School; the Department of Twin Research at Kings College London and the Center for Statistical Genetics at the University of Michigan.
